Partner Institute for Computational Biology

DDN and Helmholtz Munich Host 2023 Life Sciences Field Day to Share Research Insights and Best Practices

Retrieved on: 
Thursday, April 13, 2023

CHATSWORTH, Calif., April 13, 2023 /PRNewswire/ -- DDN®, the global leader in artificial intelligence (AI) and multi-cloud data management solutions, today announced its 2023 Life Sciences Field Day, hosted by Helmholtz Munich on May 4, 2023 at the Helmholtz Munich campus.

Key Points: 
  • Join Leading Life Sciences Innovators at the Helmholtz Munich Campus to Discuss the Latest Trends, Challenges and Solutions in Data Management, Storage and Analysis
    CHATSWORTH, Calif., April 13, 2023 /PRNewswire/ -- DDN ® , the global leader in artificial intelligence (AI) and multi-cloud data management solutions, today announced its 2023 Life Sciences Field Day , hosted by Helmholtz Munich on May 4, 2023 at the Helmholtz Munich campus.
  • The 2023 Life Sciences Field Day is a unique opportunity for innovators, researchers, and industry leaders.
  • "We are thrilled to bring together leading minds in life sciences research to gather and share knowledge, experiences, and best practices at the 2023 Life Sciences Field Day," said Tommaso Cecchi, senior director of Sales EMEA, DDN.
  • "We are honored to host the 2023 Life Sciences Field Day with the purpose of accelerating the transfer from ideas to applications with experts from across the life sciences community."

iThera Medical leads €1.9m research project to advance optoacoustic imaging technology towards AI-supported quantitative medical diagnosis

Retrieved on: 
Monday, September 13, 2021

Commenced on 1st September 2021, the project DeepOPUS (highly integrated DEtEction Platform for improved quantification and increased framerate in OPtoacoustic and UltraSound imaging) aims to further advance the established MSOT technology through use of AI.

Key Points: 
  • Commenced on 1st September 2021, the project DeepOPUS (highly integrated DEtEction Platform for improved quantification and increased framerate in OPtoacoustic and UltraSound imaging) aims to further advance the established MSOT technology through use of AI.
  • These developments will enhance diagnostic and computational performance as well as reduce the cost of the device.
  • A primary goal of the project is to increase the MSOT image quality with advanced AI methods for better usability and higher diagnostic accuracy.
  • Since its incorporation in 2010, iThera Medical develops and markets optoacoustic imaging systems for preclinical and clinical research.